Posted in

News

NIAID’s Approach on Key Immunologic Events in Autoimmune Diseases

Through the Request for Information (RFI): Inviting Comments and Suggestions on the Identification of Key Events in Autoimmune Diseases, NIAID seeks comments from the scientific community about state-of-the-art sampling and analysis techniques to identify key immunologic events underlying the onset, flare, remission, and progression of autoimmune diseases.

“Can we use ‘personalized’ medicine to prevent T1D?”

Watch the seminar presented by Michael Haller, MD, Professor & Chief of Pediatric Endocrinology and UFDI Affiliate at the Naomi Berry Diabetes Center – Columbia University. https://diabetes.ufl.edu/wordpress/files/2021/01/zoom_2.mp4…

Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes

Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes The UFDI team is dedicated to improving the lives of people affected by type 1 diabetes (T1D). Over the last 25 years, UFDI investigators have played a major role in nearly every clinical trial that has demonstrated a novel…

Dr. Stabler awarded R01 grant from the NIH NIDDK

Congratulations to Cherie Stabler, Ph.D., professor in the J. Crayton Pruitt Family Department of Biomedical Engineering, for receiving a $1.7 million RO1 grant from the NIH National Institute of Diabetes and Digestive and Kidney Diseases for her project, “Engineering Immunomodulatory Nanoscale Coatings for Protecting Islet Transplants.”…